Reduction of nitrofuran compounds by heart lipoamide dehydrogenase: role of flavin and the reactive disulfide groups.
In order to elucidate the mechanism of the biological activation of nitrofurans, the interaction of these compounds with lipoamide dehydrogenase (LipDH)** was investigated. LipDH catalysed one-electron reduction of several nitrofuran derivatives. The reaction could be demonstrated spectroscopically and was enhanced by cadmium, arsenite and anaerobiosis. The role of flavin in the nitroreductase activity was supported by (a) the nitrofuran effect on the spectral properties of anaerobic, arsenite-inhibited, NADH-reduced LipDH; (b) FAD catalytic activity in a NADH-nitrofuran model system; and (c) the nitroreductase activity of LipDH monomer. Two-electron nitrofuran reduction to less oxidized products was inhibited by cadmium, arsenite and NAD+. The possible role of reactive nitrosofuran derivatives as intermediates of the nitrofuran reduction sequence was supported by the LipDH capability for catalysing 2-nitroso-1-naphthol redox-cycling. The nitroso naphthol reduction was inhibited by cadmium and arsenite, like the two-electron nitrofuran reduction.
Sreider
C M
CM
Centro de Investigaciones Bioenergéticas, Facultad de Medicina, Buenos Aires, Argentina.
Grinblat
L
L
Stoppani
A O
AO
D000693:Anaerobiosis; D000818:Animals; D001151:Arsenic / Q000494:pharmacology; D018053:Arsenites; D002104:Cadmium / Q000494:pharmacology; D002384:Catalysis; D008058:Dihydrolipoamide Dehydrogenase / Q000378:metabolism*; D005415:Flavins / Q000378:metabolism*; D009206:Myocardium / Q000201:enzymology*; D009243:NAD / Q000378:metabolism; D009547:Nifurtimox / Q000378:metabolism / Q000494:pharmacology; D009581:Nitrofurans / Q000378:metabolism*; D010084:Oxidation-Reduction; D013056:Spectrophotometry, Ultraviolet; D013552:Swine
D018053:Arsenites; D005415:Flavins; D009581:Nitrofurans; D002104:Cadmium; D009243:NAD; D008058:Dihydrolipoamide Dehydrogenase; D009547:Nifurtimox; C015001:arsenite; D001151:Arsenic